chrisvoncsefalvay/vaers-outcomes huggingface dataset:
temperature and general joint aches within 3 hours of vaccines  (I am a Pfizer employee , but this website kept rejecting that box to enter the info); temperature and general joint aches within 3 hours of vaccines  (I am a Pfizer employee , but this website kept rejecting that box to enter the info); Other Vaccine on Same date product: Flu shot; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 at 12:15 as dose 5 (booster), single (Lot number: GH9694) at the age of 52 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 22Sep2022 as dose 1, single (Batch/Lot number: unknown), in left arm for immunisation. The patient's relevant medical history included: "If COVID prior vaccination: Yes" (unspecified if ongoing), notes: If COVID prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE :4, Unknown manufacture), for COVID-19 immunization; Covid-19 vaccine (DOSE :3, Unknown manufacture), for COVID-19 immunization; Covid-19 vaccine (DOSE :2, Unknown manufacture), for COVID-19 immunization; Covid-19 vaccine (DOSE :1, Unknown manufacture), for COVID-19 immunization. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 22Sep2022, outcome "unknown", described as "Other Vaccine on Same date product: Flu shot"; ARTHRALGIA (non-serious), BODY TEMPERATURE ABNORMAL (non-serious) all with onset 22Sep2022 at 15:00, outcome "not recovered" and all described as "temperature and general joint aches within 3 hours of vaccines (I am a Pfizer employee , but this website kept rejecting that box to enter the info)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia, body temperature abnormal.  Additional information: Adverse event treatment: Tylenol. The patient was diagnosed with COVID-19 prior to vaccination. The patient was not covid tested post vaccination. The patient had no known allergies.  No follow-up attempts are possible. No further information is expected.
Discussed with ER provider last night about this patient. The abdominal findings and mild elevation of WBC gave us a hope to manage it with antibiotics alone because of his age, COPD, AAA. He was admitted to be kept NPO, and IV Zosyn was started. The understanding was to reassess the patient this morning and make appropriate decision   Surgeon's H&P 1/10/21, Admitted from ER: Admitted with sudden onset of right lower abdominal pain started yesterday morning. Not associated with vomitings, diarrhea, fever Was seen in ER last night WBC 13K and CT scan showed appendicitis with multiple appendicoliths. This morning he is having pain, slightly worse. Not hungry WBC 11.3K. Afebrile
sore arm after getting the vaccine; This is a spontaneous report received from a Pfizer sponsored program from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced sore arm after getting the vaccine on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax & devel an inj site rxn characterized by a softball size area of swelling, redness & warmth;pt was seen by MD;
Rapid heart beat; jitteriness; fatigue; sore arm; This is a spontaneous report from a contactable health care professional (patient).  A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EN6201), via an unspecified route of administration on 05Feb2021 at 08:15 on the left arm at a single dose for COVID-19 immunization.  Medical history included sleep apnea from an unknown date and unknown if ongoing and meningioma removal on an unspecified date, 3 years ago. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced rapid heart beat, jitteriness, fatigue and sore arm on 05Feb2021 at 10:00. The patient did not receive treatment for the events. The outcome of the events was recovering. The events were reported as non-serious.
c/o runny nose  and tested positive for covid  on morning of 7/21/22- had known exposure to covid positive individual 7/18/22
Knee pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee pain.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Knee pain). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
Tested Positive for Covid, 4/04/2023 There was no adverse reaction tied to any of the 5 vaccianations I've had. The first vaccination was Moderna, Lot 040A21A.   This was my second time testing positive for COVID. The first time was before I was eligible to receive a vaccination. The only out of the ordinary symptom I had the second time was facial numbness that came and went on the left side of my face. This lasted for about 10 days but has gotten better over time.
Heart palpitation was worst after the second dose; Vascular swelling; Tired; Urinary tract infection; Bladder inflammation; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitation was worst after the second dose), CYSTITIS NONINFECTIVE (Bladder inflammation), VASCULITIS (Vascular swelling), URINARY TRACT INFECTION (Urinary tract infection) and FATIGUE (Tired) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M2A) for COVID-19 vaccination.     The patient's past medical history included Partial lung resection (Lung surgery- Part of her lung was removed) in July 2020. Concomitant products included LEVOTHYROXINE and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced CYSTITIS NONINFECTIVE (Bladder inflammation) and URINARY TRACT INFECTION (Urinary tract infection). On an unknown date, the patient experienced PALPITATIONS (Heart palpitation was worst after the second dose), VASCULITIS (Vascular swelling) and FATIGUE (Tired). In December 2021, URINARY TRACT INFECTION (Urinary tract infection) had resolved. At the time of the report, PALPITATIONS (Heart palpitation was worst after the second dose), CYSTITIS NONINFECTIVE (Bladder inflammation), VASCULITIS (Vascular swelling) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Cystoscopy: positive (Positive) Showed bladder infection. On an unknown date, Urine analysis: normal (normal) No infection.         No Treatment details were reported.  Patient stated that she was supposed to take the booster at 12:15 pm on 27-Dec-2021. She had a urinary tract infection about 2 weeks ago. She took antibiotic for 10 days now her urine shows no infection. She stated her doctor noticed that she had inflammation in her bladder. She had mild heart palpitation after the first dose, and it was worst after the second dose. She was taking Lipitor for a months before the first dose. She stop taking it because the doctor believe the bladder inflammation could be due to the medication. She stopped taking Lipitor before the second shot for a couple weeks.   This case was linked to MOD-2021-428396 (Patient Link).
felt heated/warm at the same arm of the injection; Headache; Rash that felt heated/warm at the same arm of the injection; Red at the same arm of the injection; soreness; Felt ill; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt ill), VACCINATION SITE WARMTH (felt heated/warm at the same arm of the injection), HEADACHE (Headache), VACCINATION SITE RASH (Rash that felt heated/warm at the same arm of the injection) and VACCINATION SITE ERYTHEMA (Red at the same arm of the injection) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced MALAISE (Felt ill). On an unknown date, the patient experienced VACCINATION SITE WARMTH (felt heated/warm at the same arm of the injection), HEADACHE (Headache), VACCINATION SITE RASH (Rash that felt heated/warm at the same arm of the injection), VACCINATION SITE ERYTHEMA (Red at the same arm of the injection) and MYALGIA (soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Felt ill) had resolved and VACCINATION SITE WARMTH (felt heated/warm at the same arm of the injection), HEADACHE (Headache), VACCINATION SITE RASH (Rash that felt heated/warm at the same arm of the injection), VACCINATION SITE ERYTHEMA (Red at the same arm of the injection) and MYALGIA (soreness) outcome was unknown.            No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
2 Days after Anthrax vaccination patient complans of soreness in right arm down into fingers. Lesion size 10 CM X 25 CM extending over elbow patient afebrile, NSR
Fevers,-38.2., chills on the  same date at 825 pm. The next day, fevers,-38.6, chills,  arthralgia, headache, hands and feet were very cold like I was thrown into the snowy place that I needed 3 sheets to cover me like comforter and fleece and heater at 74-75 degrees while in the small room of my son, alone.  On the 3rd day, low grade fevers-37-38.2 , persistent severe headache and muscle ache. On the 4th day, no fevers  but moderate headache and muscle ache and nausea.
Patient contacted pharmacy 08/21/2017 at 2:33 pm and notified that she was experiencing vomiting with blood, diarrhea, cold chills, fever, body aches, nausea upset stomach since on Friday evening  after receiving the immunization in the afternoon. Patient stated she received a PHENERGAN injection and LEVAQUIN from Dr over the weekend to treat the symptoms. Patient states she has lost 11 pounds and is feeling progressively worse.
On October 15th I began feeling symptoms with runny nose.  My symptoms progressed to body ache, nasal congestion, lethargic.  My symptoms lasted a total of five days.  I also tested positive for COVID-19 on October 15, 2022.  It felt like a bad cold, not even like the flu.  I had some back ache and aches in my legs.
booster dose; increase in pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP) for a Pfizer sponsored program. The reporter is the patient.  A 61 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: XELJANZ XR taken for rheumatoid arthritis, start date: 2020 (ongoing). Vaccination history included: Covid-19 vaccine (Dose: 1, manufacturer unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose: 2, manufacturer unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 2021, outcome "unknown", described as "booster dose"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "increase in pain".  Additional information: Patient reported stopping Xeljanz 7 days before and 7 days after receiving covid vaccination doses as per MD instructions, last time was about booster around about 1 month ago.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Febrile seizure on the evening of administration. Formation of mobiliform rash with recurring fevers few days after administration.
Injection site is still red and warm to the touch; Injection site is still red and warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site is still red and warm to the touch) and VACCINATION SITE WARMTH (Injection site is still red and warm to the touch) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is still red and warm to the touch) and VACCINATION SITE WARMTH (Injection site is still red and warm to the touch). At the time of the report, VACCINATION SITE ERYTHEMA (Injection site is still red and warm to the touch) and VACCINATION SITE WARMTH (Injection site is still red and warm to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
Major headache; This spontaneous case was reported by a pharmacist and describes the occurrence of HEADACHE (Major headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Major headache). At the time of the report, HEADACHE (Major headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment information was not provided.
no adverse event; patient received expired PNEUMOVAX; This spontaneous report as received from a registered nurse (also reported as medical assistant) referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.      On 21-DEC-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe, lot # S005856 for prophylaxis (dose, route and site of administration were not reported) which had expired on 03-DEC-2020 (expired product administered).  There were no adverse events or product quality issues reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S005856; expirationdate: 03-DEC-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Unknown pregnancy at time of vaccine about 6 weeks pregnant.  See form - Pt. unknown pregnant at time vaccine given.  Pt. didn't have an adverse reaction.
I had my vaccination on 11/01/2022. I had abdominal pain in 11/2022 which was very painful and could not walk. I was not able to get out of bed and I was bent at the waist. Lower abdominal pain to the right extremities to include bloating and distended abdominal. This happened in 11/2022 12/2022 and 01/2023 during my menstrual cycle. I had a doctor appointment on 01/31/2023 and was ordered an ultrasound. This appointment is in the near future.
chest and masalas pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (chest and masalas pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHEST PAIN (chest and masalas pain). At the time of the report, CHEST PAIN (chest and masalas pain) had not resolved.            No concomitant medications were reported. Patient reported that she had done her chest mammogram and chest X-ray recommended by my primary care doctor on an unknown date. Furthermore, the radiologists request to return for additional mammographic imaging with an ultrasound to complete the evaluation. No treatment information was provided by reporter. Upon in internal review on 04-Aug-2021, the age was corrected to 43 years
sugar has gone very very high since he had the Moderna Covid-19 vaccine booster; A1C last month was 9; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (sugar has gone very very high since he had the Moderna Covid-19 vaccine booster) and GLYCOSYLATED HAEMOGLOBIN INCREASED (A1C last month was 9) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A, 007B21A and 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced GLYCOSYLATED HAEMOGLOBIN INCREASED (A1C last month was 9). On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (sugar has gone very very high since he had the Moderna Covid-19 vaccine booster). At the time of the report, BLOOD GLUCOSE INCREASED (sugar has gone very very high since he had the Moderna Covid-19 vaccine booster) and GLYCOSYLATED HAEMOGLOBIN INCREASED (A1C last month was 9) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood glucose: high (High) very very high. In October 2021, Glycosylated haemoglobin: 9 (High) A1C last month was 9.         Concomitant medication of the patient was not reported.   The patent reported that he followed a diet and will have a check up with his doctor on 26-Nov-2021. All 3 doses were given at a local hospital.
Alert and oriented prior to injection. Almost immediately after injection of Hep B client stated she felt faint. She was unresponsive to voice for approximately five seconds and her legs stiffened. Client was responsive to voice again and stated she wanted to lay down. Kept client in clinic for 30 minutes after event for monitoring. Her HR immediately after injection was 60, prior to leaving clinic it was 70 and she was ambulating with a steady gait.
swelling; Interfere with motion; Pain under arm pit; Migraine with  vomiting; Migraine with  vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine with  vomiting), SWELLING (swelling), HYPOKINESIA (Interfere with motion), VOMITING (Migraine with  vomiting) and AXILLARY PAIN (Pain under arm pit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A, 016B21A and 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis. Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Aug-2021, the patient experienced MIGRAINE (Migraine with  vomiting) and VOMITING (Migraine with  vomiting). On 25-Aug-2021, the patient experienced SWELLING (swelling), HYPOKINESIA (Interfere with motion) and AXILLARY PAIN (Pain under arm pit). At the time of the report, MIGRAINE (Migraine with  vomiting), SWELLING (swelling), HYPOKINESIA (Interfere with motion), VOMITING (Migraine with  vomiting) and AXILLARY PAIN (Pain under arm pit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. Patient said that he would provide ultra sound data to Moderna, but Modena would have to follow-up with him.